Safety Shot (NASDAQ:SHOT - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.03) EPS for the quarter, Zacks reports. The business had revenue of $0.45 million for the quarter.
Safety Shot Stock Performance
Shares of SHOT traded up $0.04 during trading hours on Friday, hitting $0.65. The stock had a trading volume of 6,943,861 shares, compared to its average volume of 12,213,847. The firm has a 50-day moving average price of $0.53 and a 200 day moving average price of $0.48. Safety Shot has a fifty-two week low of $0.23 and a fifty-two week high of $1.77.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen upgraded shares of Safety Shot from a "sell" rating to a "hold" rating in a research note on Saturday.
Check Out Our Latest Analysis on SHOT
About Safety Shot
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Safety Shot, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Safety Shot wasn't on the list.
While Safety Shot currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access